Financial Achievements of Imrat Group in Numbers: Results for November-December 2024

Imrat Group is proud to share the exceptional financial outcomes achieved in the final two months of 2024. Our strategic investments across key sectors have not only reaffirmed our commitment to innovation but also delivered significant returns, highlighting the strength and foresight of our investment approach.

Key Investment Highlights:

1. Jupiter Neurosciences, Inc.
This U.S.-based clinical-stage pharmaceutical company, focusing on cutting-edge treatments for neuroinflammation, has shown remarkable potential. With an impressive monthly return of 116.81%, our ongoing investment underscores confidence in their innovative research and future growth prospects.

2. Creative Global Technology Holdings Limited
Operating out of Hong Kong, this company specializes in sourcing and reselling recycled consumer electronics. During the investment period, it delivered a substantial 154.82% monthly return. This performance reflects the growing demand for sustainable technology solutions and the company’s strategic positioning in the market.

3. Invizyne Technologies, Inc.
A frontrunner in synthetic biochemistry, Invizyne Technologies continues to push the boundaries of innovation with its unique biomanufacturing platforms. This investment yielded a strong 111.67% monthly return, reinforcing the value of breakthroughs in the biochemical sector and their contribution to sustainable industrial processes.

Driving Growth and Innovation
These outstanding results are a testament to Imrat Group’s ability to identify and invest in companies that are not only financially promising but also at the forefront of technological and environmental advancements. Our focus remains on industries that drive meaningful change, from healthcare and biotechnology to sustainable technology and beyond.

We aim to further expand our portfolio with strategic investments that align with our vision of fostering innovation and delivering long-term value.